TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20706077

Group type: EXPERIMENTAL
Intervention: Hand-assisted approach
Number of subjects: 29

Group type: COMPARATOR
Intervention: Straight laparoscopic approach
Number of subjects: 29
Study: 17590291

Group type: COMPARATOR
Intervention: Black cohosh alone (monotherapy)
Number of subjects: 6141

Group type: EXPERIMENTAL
Intervention: Black cohosh in combination with St. John's wort (combination therapy)
Number of subjects: 6141

Group type: EXPERIMENTAL
Intervention: Both therapies (Black cohosh alone and combination therapy)
Number of subjects: 6141
Study: 16305289

Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg once/day
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study: 12045767

Group type: EXPERIMENTAL
Intervention: Resin-modified glass ionomer (RMGI) adhesive
Number of subjects: 61

Group type: COMPARATOR
Intervention: Resin-based adhesive (control)
Number of subjects: 61
Study: 9776558

Group type: EXPERIMENTAL
Intervention: Urografin 76% (sodium‐meglumine diatrizoate)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Telebrix 38 (sodium‐meglumine ioxythalamate)
Number of subjects: 15

Group type: COMPARATOR
Intervention: No contrast materials (control group)
Number of subjects: 15
Study: 8527271

Group type: EXPERIMENTAL
Intervention: 12.5 mg oral ketoprofen
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 25 mg oral ketoprofen
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 50 mg oral ketoprofen
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 50 mg i.v. ketoprofen
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: R-ketoprofen (oral administration)
Number of subjects: 24
Study: 1699508

Group type: EXPERIMENTAL
Intervention: 7.5% sodium chloride
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: 7.5% sodium chloride per 6% dextran 70
Number of subjects: 106

Group type: COMPARATOR
Intervention: Lactated Ringer's (control)
Number of subjects: 106
Study: 526380

Group type: EXPERIMENTAL
Intervention: Enflurane
Number of subjects: 105

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 105
Study: 31264282

Group type: EXPERIMENTAL
Intervention: Extra-fine particle hydrofluoroalkane beclomethasone dipropionate (mean dose 355µg) after switching from fine particle ICS (mean dose 710µg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (fine particle ICS)
Number of subjects: 24
Study: 27868321

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan 97/103 mg b.i.d.
Number of subjects: 8399

Group type: COMPARATOR
Intervention: enalapril 10 mg b.i.d.
Number of subjects: 8399
Study: 25751116

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Community Treatment by Experts
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Both Treatments
Number of subjects: 101
Study: 23865840

Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGM)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Self-monitoring blood glucose
Number of subjects: 25
Study: 20924313

Group type: EXPERIMENTAL
Intervention: Synchronized NIMV (S‐NIMV) at 20/min
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Synchronized NIMV (S‐NIMV) at 40/min
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: NIMV at 20/min
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: NIMV at 40/min
Number of subjects: 16

Group type: COMPARATOR
Intervention: NCPAP
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: NIMV
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: S‐NIMV
Number of subjects: 16
Study: 19996727

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Befriending (BF)
Number of subjects: 21
Study: 16700870

Group type: EXPERIMENTAL
Intervention: Moxonidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 0
Study: 12764905

Group type: EXPERIMENTAL
Intervention: Shengfu Injection (SFI) plus chemotherapy
Number of subjects: 61
Study: 11054326

Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide sustained drug delivery device
Number of subjects: 5
Study: 12206030

Group type: EXPERIMENTAL
Intervention: Colgate Optimized Stannous Fluoride (COSF) dentifrice, containing 0.454% stannous fluoride, stannous chloride, polyphosphate, and citrate in a silica base, used twice daily for 6 months.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control dentifrice group
Number of subjects: 0
Study: 8442496

Group type: EXPERIMENTAL
Intervention: 10 microliters drop of phenylephrine
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 30 microliters drop of phenylephrine
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Eyelid closure with 10 microliters drop
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Eyelid closure with 30 microliters drop
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Eyelid closure and 10 microliters drop size
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Eyelid closure and 30 microliters drop size
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 10 microliters drop followed by eyelid closure
Number of subjects: 13
Study: 3722507

Group type: EXPERIMENTAL
Intervention: 2% topical minoxidil
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: 1% topical minoxidil
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89

Group type: COMPARATOR
Intervention: 0.01% topical minoxidil
Number of subjects: 89

Group type: COMPARATOR
Intervention: 0.1% topical minoxidil
Number of subjects: 89
Study: 31511069

Group type: EXPERIMENTAL
Intervention: Atezolizumab (anti-PD-L1 antibody) treatment
Number of subjects: 14
Study: 27220057

Group type: EXPERIMENTAL
Intervention: Peer-facilitated cognitive-behavioral bibliotherapy (n = 31)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Wait-list control (n = 31)
Number of subjects: 62
Study: 25909982

Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon pump (IABP)
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Left ventricular assist device (Impella 2.5)
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Risk scores (Euroscore, STS mortality score, STS morbidity and mortality score, Mayo Clinic risk score, New York state PCI risk score)
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Risk scores
Number of subjects: 427
Study: 22496093

Group type: EXPERIMENTAL
Intervention: Stimulating music
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sedating music
Number of subjects: 60

Group type: COMPARATOR
Intervention: Quiet rest
Number of subjects: 60
Study: 22041945

Group type: EXPERIMENTAL
Intervention: Yoga (n = 156)
Number of subjects: 313

Group type: COMPARATOR
Intervention: Usual care (n = 157)
Number of subjects: 313
Study: 18775942

Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy (SMT) in addition to standard care
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 104
Study: 16514326

Group type: EXPERIMENTAL
Intervention: Cold detection threshold
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Vibration perception threshold and loss of ankle reflexes
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Cold detection threshold (when vibration perception threshold and loss of ankle reflexes were removed)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Heat pain tests
Number of subjects: 191
Study: 15269869

Group type: EXPERIMENTAL
Intervention: Miniplate osteosynthesis and intermaxillary ligation
Number of subjects: 59

Group type: COMPARATOR
Intervention: Arch bar splints fixation and intermaxillary ligation
Number of subjects: 59
Study: 11712724

Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl
Number of subjects: 13
Study: 9149190

Group type: EXPERIMENTAL
Intervention: Oral preparation (one bottle of magnesium citrate and two 'Dulcolax' tablets)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Enema preparation (two Fleet's enemas)
Number of subjects: 70
Study: 8196323

Group type: EXPERIMENTAL
Intervention: aiconol in the form of oil (Group 1, 51 subjects)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: protein dietetic caviar with 3% aiconol (Group 2, 35 subjects)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: protein-oil emulsion containing 20% aiconol (Group 3, 38 subjects)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: gelatin aiconol in capsules (Group 4, 40 subjects)
Number of subjects: 164
Study: 3286579

Group type: EXPERIMENTAL
Intervention: Early refeeding (6-h)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Late refeeding (24-h)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Breast milk or cow's milk diet in both early and late refeeding groups
Number of subjects: 90
Study: 31616933

Group type: EXPERIMENTAL
Intervention: Agriculture and nutrition behavior change communication (BCC) intervention implemented through community-based childcare centers
Number of subjects: 1248

Group type: EXPERIMENTAL
Intervention: Agriculture and nutrition behavior change communication (BCC) intervention
Number of subjects: 1248
Study: 30243109

Group type: EXPERIMENTAL
Intervention: Family-centered empowerment intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 29182212

Group type: EXPERIMENTAL
Intervention: Total etch approach using phosphoric acid
Number of subjects: 64

Group type: COMPARATOR
Intervention: Self-etch approach using a Universal dentine bonding agent (Scotchbond Universal)
Number of subjects: 64
Study: 26016658

Group type: COMPARATOR
Intervention: Nap (30 minutes)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Bright light exposure (30 minutes under bright blue light)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Wake (30 minutes watching a documentary)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (30 minutes watching a documentary under dim orange light)
Number of subjects: 25
Study: 23188121

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg
Number of subjects: 2303

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg
Number of subjects: 2303

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2303
Study: 21645332

Group type: EXPERIMENTAL
Intervention: 200 mg perhexiline maleate
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 19546692

Group type: EXPERIMENTAL
Intervention: Oral melatonin 0.05 mg/kg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Oral melatonin 0.2 mg/kg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Oral melatonin 0.4 mg/kg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oral midazolam 0.5 mg/kg
Number of subjects: 100
Study: 16988202

Group type: EXPERIMENTAL
Intervention: Palonosetron 0.25 mg administered as a 15-minute 50-mL intravenous infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Palonosetron 0.25 mg administered as a 30-second 5-mL infusion
Number of subjects: 0
Study: 15561476

Group type: EXPERIMENTAL
Intervention: Incentives for breath COs at or below the 10th percentile
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Incentives for breath COs at or below the 30th percentile
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Incentives for breath COs at or below the 50th percentile
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Incentives for breath COs at or below the 70th percentile
Number of subjects: 102
Study: 11095085

Group type: EXPERIMENTAL
Intervention: ILC + stent
Number of subjects: 35

Group type: COMPARATOR
Intervention: ILC only
Number of subjects: 35
Study: 9243334

Group type: EXPERIMENTAL
Intervention: External valvuloplasty with Silicone prosthesis under Doppler control
Number of subjects: 113

Group type: COMPARATOR
Intervention: High ligation or disconnection of the junction
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Both operations (External valvuloplasty and High ligation/disconnection)
Number of subjects: 113
Study: 8500313

Group type: EXPERIMENTAL
Intervention: Media (TV, radio, newspapers)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neighborhood promotion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direct mail
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Worksite promotion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Referral by other study participants
Number of subjects: 0
Study: 3108980

Group type: EXPERIMENTAL
Intervention: Ventilation (Ve) plots
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: CO2 production (VCO2) plots
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Respiratory exchange ratio (R) plots
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ventilatory equivalent for oxygen (Ve/VO2) plots
Number of subjects: 6
Study: 30121611

Group type: EXPERIMENTAL
Intervention: Peer support system
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Peer support system plus automated daily supportive/reminder text messages
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Automated daily supportive/reminder text messages alone
Number of subjects: 180

Group type: COMPARATOR
Intervention: Treatment as usual follow-up care
Number of subjects: 180
Study: 27042788

Group type: EXPERIMENTAL
Intervention: DynaMesh®‐IPOM
Number of subjects: 76

Group type: COMPARATOR
Intervention: Gore® DUALMESH® Plus
Number of subjects: 76
Study: 24211172

Group type: EXPERIMENTAL
Intervention: Device monitoring with the ForeseeHome device
Number of subjects: 1520

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1520
Study: 23314695

Group type: EXPERIMENTAL
Intervention: IgM-enriched immunoglobulin (5 ml/kg via 8 h IV-infusion for three consecutive days)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (5 ml/kg via 8 h IV-infusion for three consecutive days)
Number of subjects: 33
Study: 20063934

Group type: EXPERIMENTAL
Intervention: Implementation intention + SMS plan reminder
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Implementation intention + SMS goal reminder
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control
Number of subjects: 149
Study: 19082406

Group type: EXPERIMENTAL
Intervention: 2.5 mg of 0.5% hyperbaric bupivacaine with 2.5 microg of sufentanil and 30 microg of clonidine (CLON/HYPER Group)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 2.5 mg of 0.5% isobaric bupivacaine with 2.5 microg of sufentanil and 30 microg of clonidine (CLON/ISO Group)
Number of subjects: 22
Study: 20554428

Group type: EXPERIMENTAL
Intervention: Electronic reminders (ERs)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Control group (no electronic reminders)
Number of subjects: 148
Study: 16210048

Group type: EXPERIMENTAL
Intervention: IVL745 (20 mg, twice daily for 7 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: IVL745
Number of subjects: 16
Study: 12898875

Group type: EXPERIMENTAL
Intervention: Hypertensive obese patients
Number of subjects: 31

Group type: COMPARATOR
Intervention: Patients with systemic hypertension and normal BMI (control group)
Number of subjects: 31
Study: 9797161

Group type: EXPERIMENTAL
Intervention: Magnetization transfer ratios in multiple sclerosis lesions
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Myelin water percentages in multiple sclerosis lesions
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Magnetization transfer ratios and myelin water percentages
Number of subjects: 19
Study: 9098463

Group type: EXPERIMENTAL
Intervention: EE/desogestrel
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: EE/gestodene
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (IUD)
Number of subjects: 100
Study: 2473515

Group type: EXPERIMENTAL
Intervention: Colloid cardioplegic solution (35 g dextran 40 added to St Thomas II solution)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Standard crystalloid cardioplegic solution
Number of subjects: 55
Study: 348734

Group type: EXPERIMENTAL
Intervention: 0.035% w/v alexidine.2HCL mouthwash
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 214
Study: 11304817

Group type: EXPERIMENTAL
Intervention: Subtenon ropivacaine
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 30656460

Group type: EXPERIMENTAL
Intervention: Prospective ECG-triggered sequential protocol (group 1)
Number of subjects: 63

Group type: COMPARATOR
Intervention: High-pitch spiral protocol (group 2)
Number of subjects: 63
Study: 29738810

Group type: EXPERIMENTAL
Intervention: Novel tobacco vapor product (NTV)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional cigarettes (CC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Smoking abstinence (SA)
Number of subjects: 60
Study: 27188795

Group type: EXPERIMENTAL
Intervention: Active transcranial direct current stimulation (tDCS)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Placebo transcranial direct current stimulation (tDCS)
Number of subjects: 340
Study: 25008877

Group type: EXPERIMENTAL
Intervention: EPO treatment (200 IU/(kg.d) by intravenous infusion for 7 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal control group (healthy full-term neonates)
Number of subjects: 40
Study: 21859516

Group type: COMPARATOR
Intervention: Nutritional intervention consisting of joint meal preparation and activities for children and parents, administered once weekly by a nutrition expert for 6 months.
Number of subjects: 348
Study: 20525960

Group type: EXPERIMENTAL
Intervention: Toluidine blue screening (TBS) group
Number of subjects: 7975

Group type: COMPARATOR
Intervention: Visual screening group (control)
Number of subjects: 7975
Study: 17603411

Group type: EXPERIMENTAL
Intervention: Early Intervention (EI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Community Mental Health Team (CMHT)
Number of subjects: 40
Study: 15842140

Group type: EXPERIMENTAL
Intervention: Shennong No. 33 (SN33) in addition to comprehensive therapy
Number of subjects: 129

Group type: COMPARATOR
Intervention: Comprehensive therapy without SN33
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Shennong No. 33 (SN33)
Number of subjects: 129
Study: 12855972

Group type: EXPERIMENTAL
Intervention: Treatment Group (prophylactic macular photocoagulation)
Number of subjects: 156

Group type: COMPARATOR
Intervention: No Treatment Group (control)
Number of subjects: 156
Study: 10569644

Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (LA) 600 mg/d
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol (AT) 400 IU/d
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Combination of LA and AT
Number of subjects: 31
Study: 8906516

Group type: EXPERIMENTAL
Intervention: DD genotype
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Combined IMT plaque values
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Total population
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Genotype
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Carotid plaques
Number of subjects: 515
Study: 1878735

Group type: EXPERIMENTAL
Intervention: Human recombinant GM-CSF
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7063290

Group type: EXPERIMENTAL
Intervention: Flunisolide aerosol (0.5 mg twice a day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 29381789

Group type: EXPERIMENTAL
Intervention: Automated Self‐Administered 24‐h recalls (ASA24s)
Number of subjects: 1075

Group type: EXPERIMENTAL
Intervention: 4‐d food records (4DFRs)
Number of subjects: 1075

Group type: EXPERIMENTAL
Intervention: Food‐frequency questionnaires (FFQs)
Number of subjects: 1075

Group type: EXPERIMENTAL
Intervention: Multiple ASA24s and 4DFR
Number of subjects: 1075

Group type: EXPERIMENTAL
Intervention: Energy adjustment for FFQs
Number of subjects: 1075
Study: 27187845

Group type: EXPERIMENTAL
Intervention: Gratitude journaling intervention
Number of subjects: 70

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 70
Study: 24707021

Group type: EXPERIMENTAL
Intervention: Lovaza (3360 mg docosahexaenoic acid + eicosapentaenoic acid per day)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25

Group type: COMPARATOR
Intervention: Comparison between Lovaza and Placebo
Number of subjects: 25
Study: 22379242

Group type: EXPERIMENTAL
Intervention: Automatic event detection (AED) using a positive airway pressure (PAP) device
Number of subjects: 115

Group type: COMPARATOR
Intervention: Manual scoring of polysomnography (PSG)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: PAP AED
Number of subjects: 115

Group type: COMPARATOR
Intervention: Manual scoring
Number of subjects: 115
Study: 20709301

Group type: EXPERIMENTAL
Intervention: Aquatic Exercise (AQE)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Land-based Exercise (LBE)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 75
Study: 17431065

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS to the right DLPFC
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS to the left DLPFC
Number of subjects: 45

Group type: COMPARATOR
Intervention: 1 Hz rTMS to the left DLPFC
Number of subjects: 45

Group type: COMPARATOR
Intervention: sham TMS
Number of subjects: 45
Study: 16025975

Group type: EXPERIMENTAL
Intervention: Acupuncture intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 0
Study: 12197195

Group type: EXPERIMENTAL
Intervention: Indapamide 2.5 mg
Number of subjects: 42

Group type: COMPARATOR
Intervention: Hydrochlorothiazide 12.5 mg
Number of subjects: 42
Study: 10220696

Group type: EXPERIMENTAL
Intervention: Steroid pretreatment (methylprednisolone, 30 mg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7880703

Group type: EXPERIMENTAL
Intervention: Fentanyl 50 micrograms
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Bupivacaine 50 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fentanyl in 0.25% bupivacaine (25 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fentanyl in 0.125% bupivacaine (12.5 mg)
Number of subjects: 24
Study: 1369865

Group type: EXPERIMENTAL
Intervention: Immobilization of the forearm
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Full-arm plaster
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Full-arm plaster with X-ray follow-up (7th to 10th day after reduction)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 97
Study: 638249

Group type: EXPERIMENTAL
Intervention: Low-dose 'concentration x time' (C x T) schedule of 1 mg every 12 hr for 3 days
Number of subjects: 19

Group type: COMPARATOR
Intervention: Single injections of 12 mg/sq m/dose
Number of subjects: 19